Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
BioMed Research International is Scopus-indexed (Q1, CiteScore 9.4), WoS ESCI. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2314-6133Verify ISSN ↗2314-6141Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: About US$2,680 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Microbiology (all) | 6 / 63 | 91st | Q1 |
| Biochemistry, Genetics and Molecular Biology (all) | 30 / 223 | 86th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 9.4.
BioMed Research International is Q1 in Immunology and Microbiology (all) (rank 6 of 63) and Q1 in Biochemistry, Genetics and Molecular Biology (all) (rank 30 of 223), by CiteScore 2025.
BioMed Research International is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9.4, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.748, quartile Q2, with an H-index of 219.
The publisher lists an article processing charge of about US$2,680 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
BioMed Research International is published by John Wiley and Sons Ltd. Its print ISSN is 2314-6133 and its online ISSN is 2314-6141.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
BioMed Research International has an h-index of 259 and a 2-year mean of 1.17 citations per paper (OpenAlex). Its Scopus CiteScore is 9.4, quartile Q1. On 2-year citations it ranks #42 of 62 Scopus journals in Immunology and Microbiology (all).
BioMed Research International published 207 papers in 2025; its busiest recent year was 2020 with 2,508. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from Iran (18%), China (13.5%) and Ethiopia (7.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2,034 retracted papers are recorded (73.3 per 1,000 papers). The Problematic Paper Screener flags 84 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.